| 000 | 01361 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513201306.0 | ||
| 264 | 0 | _c20000229 | |
| 008 | 200002s 0 0 ger d | ||
| 022 | _a0933-4548 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKreck, C | |
| 245 | 0 | 0 |
_a[Social medicine aspects of growth hormone treatment of children]. _h[electronic resource] |
| 260 |
_bVersicherungsmedizin _cDec 1999 |
||
| 300 |
_a186-93 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aBody Height _xdrug effects |
| 650 | 0 | 4 |
_aBody Weight _xdrug effects |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aDrug Approval _xlegislation & jurisprudence |
| 650 | 0 | 4 |
_aDwarfism, Pituitary _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGermany |
| 650 | 0 | 4 |
_aHuman Growth Hormone _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aInsurance Coverage _xlegislation & jurisprudence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNational Health Programs _xlegislation & jurisprudence |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aBingel, S | |
| 700 | 1 | _aHeberlein, E | |
| 700 | 1 | _aSchepping, M | |
| 700 | 1 | _aWinkler, U | |
| 773 | 0 |
_tVersicherungsmedizin _gvol. 51 _gno. 4 _gp. 186-93 |
|
| 999 |
_c10585547 _d10585547 |
||